Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
Go back to Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives| (NASDAQ: ABUS) | Delayed: 4.21 -0.07 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.28 | 52 Week High | $5.88 | |||
| Open | $4.28 | 52 Week Low | $2.65 | |||
| Day High | $4.30 | P/E | N/A | |||
| Day Low | $4.14 | EPS | $0.00 | |||
| Volume | 2,526,176 | |||||
| (NASDAQ: ABUS) | Delayed: 4.21 -0.07 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.28 | 52 Week High | $5.88 | |||
| Open | $4.28 | 52 Week Low | $2.65 | |||
| Day High | $4.30 | P/E | N/A | |||
| Day Low | $4.14 | EPS | $0.00 | |||
| Volume | 2,526,176 | |||||



